BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2008

View Archived Issues

LY-450139 safe and well tolerated in Japanese subjects

Read More

Beneficial activity of CHF-5074 seen in mouse, guinea pig models of Alzheimer's disease

Read More

Imaging study reveals effects of GSK-189254 on cognition

Read More

Antitumor activity seen with PF-00299804 in several human xenograft models

Read More

NeuroPharma describes glycogen synthase kinase-3 inhibitor derived from marine organism

Read More

Meda and Valeant form joint ventures in Australia, Canada and Mexico

Read More

Celgene terminates satraplatin agreement with GPC Biotech

Read More

Mipomersen enters second phase III trial

Read More

Bayer acquires preclinical oncology program from Nycomed

Read More

Once-daily administration of RDEA-806 is safe and active against HIV in a phase II study

Read More

FDA grants orphan drug designation to SuperGen's MP-470 in glioblastoma multiforme

Read More

Cleveland receives notice of allowance from FDA to initiate phase I trial of Protectan CBLB-502

Read More

OrthoLogic reports positive results from preclinical study of Chrysalin in acute heart disease

Read More

Sonus signs exclusive in-licensing agreement with Bayer Healthcare for caspase activators

Read More

InNexus initiates primate study of DXL-625 antibody and adds DXLr-120 to pipeline

Read More

University of Texas Southwestern Medical Center initiates clinical trial of DOR's RiVax

Read More

Generex initiates enrollment in phase I clinical trial of AE-37 cancer vaccine

Read More

BioSante reacquires Elestrin from Nycomed

Read More

Oramed reports positive results from phase IIa clinical trial of ORMD-0801 in type 2 diabetes

Read More

Novel compounds for the treatment of cardiovascular disorders described in recent patents

Read More

HIV vaccine Vacc-4x enters phase IIb study

Read More

Patents disclose novel antiplatelet and anticoagulant compounds

Read More

Novel agents potentially useful for the treatment of cancer reported in recent patents

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing